clarithromycin

clarithromycin is a lipid of Polyketides (PK) class. Clarithromycin is associated with abnormalities such as Helicobacter Pylori Infection, Infection, Coinfection, Gastritis and Peptic Ulcer. The involved functions are known as Point Mutation, Increased Sensitivy, Bacterial resistance, urease activity and Mutation. Clarithromycin often locates in Blood, Gastric mucosa, Biopsy sample, Respiratory System and Entire gastrointestinal tract. The associated genes with clarithromycin are Genes, rRNA, rRNA Operon, Genome, HM13 gene and GDF15 gene. The related lipids are 9,11-linoleic acid, Steroids, Lysophosphatidylcholines, Lipopolysaccharides and 4-hydroxycholesterol. The related experimental models are Mouse Model, Knock-out and Experimental Pneumococcal Meningitis.

Cross Reference

Introduction

To understand associated biological information of clarithromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with clarithromycin?

clarithromycin is suspected in Infection, Helicobacter Pylori Infection, Pneumonia, Respiratory Tract Infections, PARKINSON DISEASE, LATE-ONSET, Community acquired pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with clarithromycin

MeSH term MeSH ID Detail
Abnormalities, Drug-Induced D000014 10 associated lipids
Abortion, Spontaneous D000022 12 associated lipids
Abscess D000038 13 associated lipids
Achlorhydria D000126 1 associated lipids
Actinomycetales Infections D000193 4 associated lipids
Adenocarcinoma D000230 166 associated lipids
Angina Pectoris D000787 27 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Arteriosclerosis D001161 86 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Infectious D001170 8 associated lipids
Bacterial Infections D001424 21 associated lipids
Bacteriuria D001437 7 associated lipids
Barrett Esophagus D001471 3 associated lipids
Bartonella Infections D001474 3 associated lipids
Body Weight D001835 333 associated lipids
Boutonneuse Fever D001907 5 associated lipids
Bradycardia D001919 13 associated lipids
Bronchial Spasm D001986 18 associated lipids
Bronchiectasis D001987 7 associated lipids
Bronchiolitis D001988 6 associated lipids
Bronchiolitis Obliterans D001989 8 associated lipids
Bronchitis D001991 6 associated lipids
Carcinoma, Basal Cell D002280 6 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Chlamydia Infections D002690 7 associated lipids
Chromoblastomycosis D002862 2 associated lipids
Colitis D003092 69 associated lipids
Confusion D003221 4 associated lipids
Conjunctival Neoplasms D003230 3 associated lipids
Conjunctivitis, Bacterial D003234 3 associated lipids
Cross Infection D003428 9 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Cysts D003560 4 associated lipids
Dermatitis, Exfoliative D003873 10 associated lipids
Drug Eruptions D003875 30 associated lipids
Dermatomycoses D003881 17 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diarrhea D003967 32 associated lipids
Diphtheria D004165 2 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Duodenitis D004382 4 associated lipids
Duodenogastric Reflux D004383 2 associated lipids
Dyspepsia D004415 5 associated lipids
Dyspnea D004417 10 associated lipids
Ecchymosis D004438 3 associated lipids
Empyema D004653 3 associated lipids
Empyema, Tuberculous D004654 1 associated lipids
Per page 10 20 50 100 | Total 242

PubChem Associated disorders and diseases

What pathways are associated with clarithromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with clarithromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with clarithromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with clarithromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with clarithromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with clarithromycin?

Mouse Model

Mouse Model are used in the study 'Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone.' (Hirao S et al., 2011), Mouse Model are used in the study 'Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.' (Hafner R et al., 1998), Mouse Model are used in the study 'Clarithromycin attenuates mastectomy-induced acute inflammatory response.' (Chow LW et al., 2000) and Mouse Model are used in the study 'In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.' (Bui KQ et al., 2000).

Knock-out

Knock-out are used in the study 'Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38).' (Nash KA, 2003).

Experimental Pneumococcal Meningitis

Experimental Pneumococcal Meningitis are used in the study 'Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid.' (Maniu CV et al., 2001).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with clarithromycin

Download all related citations
Per page 10 20 50 100 | Total 7636
Authors Title Published Journal PubMed Link
Gysel M et al. Torsades de pointes following clarithromycin treatment. 2013 Expert Rev Cardiovasc Ther pmid:24147515
Megraud F et al. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. 2013 Gut pmid:22580412
Sierra F et al. Pilot study: miscellaneous therapy is highly successful for Helicobacter pylori eradication. 2013 Aliment. Pharmacol. Ther. pmid:23656465
Jiang JW et al. Synthesis and antibacterial evaluation of a novel series of 10-hydroxyl ketolide derivatives. 2013 Bioorg. Med. Chem. Lett. pmid:23591116
Odagiri T et al. Design, synthesis, and biological evaluations of novel 7-[7-amino-7-methyl-5-azaspiro[2.4]heptan-5-yl]-8-methoxyquinolines with potent antibacterial activity against respiratory pathogens. 2013 J. Med. Chem. pmid:23409972
Seyedmajidi S et al. Penbactam for Helicobacter pylori eradication: a randomised comparison of quadruple and triple treatment schedules in an Iranian population. 2013 Arab J Gastroenterol pmid:23622801
Bessa LJ et al. Helicobacter pylori free-living and biofilm modes of growth: behavior in response to different culture media. 2013 APMIS pmid:23237527
Qvist T et al. First report of lung transplantation in a patient with active pulmonary Mycobacterium simiae infection. 2013 Transplant. Proc. pmid:23267789
Secka O et al. Antimicrobial susceptibility and resistance patterns among Helicobacter pylori strains from The Gambia, West Africa. 2013 Antimicrob. Agents Chemother. pmid:23263004
Mueck W et al. Co-administration of rivaroxaban with drugs that share its elimination pathways: pharmacokinetic effects in healthy subjects. 2013 Br J Clin Pharmacol pmid:23305158
Joosten M et al. Case report: Helicobacter suis infection in a pig veterinarian. 2013 Helicobacter pmid:23551953
Unai S et al. Sternal wound infection caused by Mycobacterium chelonae. 2013 J Card Surg pmid:23941599
Faraji F et al. The effect of Helicobacter pylori eradication on migraine: a randomized, double blind, controlled trial. 2012 Nov-Dec Pain Physician pmid:23159967
Eremenko AA et al. [Effect of clarithromycin on the systemic inflammatory response syndrome severity in patients after myocardial revascularization surgery]. 2012 May-Jun Anesteziol Reanimatol pmid:22993930
Singh V et al. Vesicular palmoplantar pityriasis rosea. 2012 Mar-Apr Skinmed pmid:22545332
Gutiérrez-Castrellón P et al. Efficacy and safety of clarithromycin in pediatric patients with upper respiratory infections: a systematic review with meta-analysis. 2012 Mar-Apr Rev. Invest. Clin. pmid:22991774
Rajendiran S et al. Increased protein carbonylation and decreased antioxidant status in anemic H. pylori infected patients: effect of treatment. 2012 Jul-Aug Saudi J Gastroenterol pmid:22824768
De Sanctis V et al. Anti-Helicobacter pylori therapy in primary MALT lymphoma of rectum. 2012 Jul-Aug Tumori pmid:23052174
Figueroa M et al. [Antimicrobial susceptibility of Helicobacter pylori with chronic gastritis]. 2012 Jan-Mar Biomedica pmid:23235785
de Lalibera IB et al. Meningoencephalitis associated with Mycoplasma pneumoniae. 2012 Jan-Mar Einstein (Sao Paulo) pmid:23045836
Dhillon GS et al. Clarithromycin for prevention of bronchiolitis obliterans syndrome in lung allograft recipients. 2012 Jan-Feb Clin Transplant pmid:21352378
Onsun N et al. Impact of Helicobacter pylori infection on severity of psoriasis and response to treatment. 2012 Jan-Feb Eur J Dermatol pmid:22063790
Montero-Tinnirello J et al. [Pulmonary hemorrhage due to leptospirosis]. 2012 Jan-Feb Med Intensiva pmid:21592620
Dai WQ et al. The eradicating Helicobacter pylori infection in duodenal ulcer patients by three short-term triple therapies in China: a multicenter clinical comparative study. 2012 Jan-Feb Hepatogastroenterology pmid:22260837
VanderHeyden TR et al. Granulomatous hepatitis due to Bartonella henselae infection in an immunocompetent patient. 2012 BMC Infect. Dis. pmid:22269175
Glatstein M et al. Lung abscess due to non-tuberculous, non-Mycobacterium fortuitum in a neonate. 2012 Pediatr. Pulmonol. pmid:22451300
Matsushima M and Takagi A "Is it effective?" to "How to use it?": the era has changed in probiotics and functional food products against Helicobacter pylori infection. 2012 J. Gastroenterol. Hepatol. pmid:22515805
Fujita Y et al. Pulmonary Actinomyces graevenitzii infection presenting as organizing pneumonia diagnosed by PCR analysis. 2012 J. Med. Microbiol. pmid:22516132
Stout JE and Floto RA Treatment of Mycobacterium abscessus: all macrolides are equal, but perhaps some are more equal than others. 2012 Am. J. Respir. Crit. Care Med. pmid:23118083
Park HS et al. Placental transfer of clarithromycin in human pregnancies with preterm premature rupture of membranes. 2012 J Perinat Med pmid:23095192
Milani M et al. The status of antimicrobial resistance of Helicobacter pylori in Eastern Azerbaijan, Iran: comparative study according to demographics. 2012 J. Infect. Chemother. pmid:22581031
Perić A et al. Effect of long-term, low-dose clarithromycin on T helper 2 cytokines, eosinophilic cationic protein and the 'regulated on activation, normal T cell expressed and secreted' chemokine in the nasal secretions of patients with nasal polyposis. 2012 J Laryngol Otol pmid:22559798
Yamazaki Y et al. Antimicrobial and anti-inflammatory effects of clarithromycin on Mycobacterium avium complex replication in cultured human bronchial epithelial cells. 2012 J. Infect. Chemother. pmid:22370922
Kim HS et al. Serial CT findings of Mycobacterium massiliense pulmonary disease compared with Mycobacterium abscessus disease after treatment with antibiotic therapy. 2012 Radiology pmid:22371609
Hutson JR et al. Use of clarithromycin and adverse cardiovascular events among older patients receiving donepezil: a population-based, nested case-control study. 2012 Drugs Aging pmid:22372724
Hegazy SK et al. Effect of clarithromycin and fluconazole on the pharmacokinetics of montelukast in human volunteers. 2012 Eur. J. Clin. Pharmacol. pmid:22392555
Zarogoulidis P et al. Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases. 2012 Eur. J. Clin. Pharmacol. pmid:22105373
Bruin JP et al. Wild-type MIC distribution and epidemiological cut-off values in clinical Legionella pneumophila serogroup 1 isolates. 2012 Diagn. Microbiol. Infect. Dis. pmid:22100012
van Ingen J et al. Drug susceptibility testing and pharmacokinetics question current treatment regimens in Mycobacterium simiae complex disease. 2012 Int. J. Antimicrob. Agents pmid:22099521
Bondon-Guitton E et al. Drug-induced gingival overgrowth: a study in the French Pharmacovigilance Database. 2012 J. Clin. Periodontol. pmid:22519416
Vazquez-Lago JM et al. Attitudes of primary care physicians to the prescribing of antibiotics and antimicrobial resistance: a qualitative study from Spain. 2012 Fam Pract pmid:22016323
Bosnar M et al. N'-substituted-2'-O,3'-N-carbonimidoyl bridged macrolides: novel anti-inflammatory macrolides without antimicrobial activity. 2012 J. Med. Chem. pmid:22697905
Yamamoto Y et al. A case of refractory chronic respiratory tract infection due to Pseudomonas aeruginosa successfully controlled by combination of clarithromycin and azithromycin. 2012 Intern. Med. pmid:22687847
Sezikli M et al. Supplementing vitamins C and E to standard triple therapy for the eradication of Helicobacter pylori. 2012 J Clin Pharm Ther pmid:21740452
Nishizawa T et al. Proton pump inhibitor-amoxicillin-clarithromycin versus proton pump inhibitor-amoxicillin-metronidazole as first-line Helicobacter pylori eradication therapy. 2012 J Clin Biochem Nutr pmid:22962528
Amin M et al. Green synthesis of silver nanoparticles through reduction with Solanum xanthocarpum L. berry extract: characterization, antimicrobial and urease inhibitory activities against Helicobacter pylori. 2012 Int J Mol Sci pmid:22949839
Kwan BY and Rabheru K Manic episode associated with clarithromycin in a patient with medically treated depression. 2012 Prim Care Companion CNS Disord pmid:22943025
Cheung JP et al. Mycobacterium marinum infection of the hand and wrist. 2012 J Orthop Surg (Hong Kong) pmid:22933682
Zong W et al. The first case of cutaneous infection with Mycobacterium parascrofulaceum. 2012 Ther Clin Risk Manag pmid:22930638
D'Elios MM et al. Helicobacter pylori: usefulness of an empirical fourth-line rifabutin-based regimen. 2012 Expert Rev Gastroenterol Hepatol pmid:22928895
Wu TS et al. Fish tank granuloma caused by Mycobacterium marinum. 2012 PLoS ONE pmid:22911774
Jang YJ et al. Maxillary sinus hypoplasia with a patent ostiomeatal complex: A therapeutic dilemma. 2012 Auris Nasus Larynx pmid:21571467
Kido T et al. Two cases of primary ciliary dyskinesia with different responses to macrolide treatment. 2012 Intern. Med. pmid:22576394
Hansomburana P et al. Prevalence of single nucleotide mutation in clarithromycin resistant gene of Helicobacter pylori: a 32-months prospective study by using hybridization real time polymerase chain reaction. 2012 J Med Assoc Thai pmid:22619884
Rimbara E et al. Molecular epidemiologic analysis and antimicrobial resistance of Helicobacter cinaedi isolated from seven hospitals in Japan. 2012 J. Clin. Microbiol. pmid:22593597
Kant S et al. Extra-pulmonary primary multidrug-resistant tubercular lymphadenitis in an HIV negative patient. 2012 BMJ Case Rep pmid:22605844
Korkmaz S et al. Unusual manifestations of acute Q fever: autoimmune hemolytic anemia and tubulointerstitial nephritis. 2012 Ann. Clin. Microbiol. Antimicrob. pmid:22607576
Oh HS et al. Ten-day sequential therapy is more effective than proton pump inhibitor-based therapy in Korea: a prospective, randomized study. 2012 J. Gastroenterol. Hepatol. pmid:21916989
Wong BC et al. Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions. 2012 Gut pmid:21917649
Kim BJ et al. Discovery of a novel hsp65 genotype within Mycobacterium massiliense associated with the rough colony morphology. 2012 PLoS ONE pmid:22693637
Karczewska E et al. Variability in Prevalence of Helicobacter pylori Strains Resistant to Clarithromycin and Levofloxacin in Southern Poland. 2012 Gastroenterol Res Pract pmid:22693490
Tuchman SA et al. Lenalidomide before and after Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma. 2012 Adv Hematol pmid:22690220
Ojetti V et al. Impact of Lactobacillus reuteri Supplementation on Anti-Helicobacter pylori Levofloxacin-Based Second-Line Therapy. 2012 Gastroenterol Res Pract pmid:22690211
Ogoshi T et al. A case of Good syndrome with pulmonary lesions similar to diffuse panbronchiolitis. 2012 Intern. Med. pmid:22576393
Tseng CH Diabetes, insulin use and Helicobacter pylori eradication: a retrospective cohort study. 2012 BMC Gastroenterol pmid:22571603
Park SK et al. Regression of Advanced Gastric MALT Lymphoma after the Eradication of Helicobacter pylori. 2012 Gut Liver pmid:22570759
Shiota S et al. Association of helicobacter pylori dupA with the failure of primary eradication. 2012 J. Clin. Gastroenterol. pmid:22298090
Bayles T et al. Clarithromycin for community-acquired pneumonia: beware drug interactions. 2012 Intern Med J pmid:23046194
Liang JH et al. Structure-activity relationships of novel alkylides: 3-O-arylalkyl clarithromycin derivatives with improved antibacterial activities. 2012 Eur J Med Chem pmid:22301216
Ankomah P and Levin BR Two-drug antimicrobial chemotherapy: a mathematical model and experiments with Mycobacterium marinum. 2012 PLoS Pathog. pmid:22253599
Lembo G et al. Successful treatment of Mycobacterium terrae complex infection of the knee. 2012 J Clin Rheumatol pmid:23047536
Melter O et al. Bartonella quintana transmission from mite to family with high socioeconomic status. 2012 Emerging Infect. Dis. pmid:22257438
Kjoller E et al. Good interobserver agreement was attainable on outcome adjudication in patients with stable coronary heart disease. 2012 J Clin Epidemiol pmid:22257841
Conde-Álvarez R et al. The lipopolysaccharide core of Brucella abortus acts as a shield against innate immunity recognition. 2012 PLoS Pathog. pmid:22589715
Suzuki T Meibomitis-related keratoconjunctivitis: implications and clinical significance of meibomian gland inflammation. 2012 Cornea pmid:23038034
Nakajima S et al. Multiple-antibiotic-resistant Helicobacter pylori infection eradicated with a tailor-made quadruple therapy. 2012 J. Gastroenterol. Hepatol. pmid:22486882
Misiewicz JJ Management of Helicobacter pylori-related disorders. 2012 Eur J Gastroenterol Hepatol pmid:22498902
Pasqualetti G et al. Clarithromycin-induced rhabdomyolysis: a case report. 2012 Int J Gen Med pmid:22505827
Sachs G and Scott DR Helicobacter pylori: Eradication or Preservation. 2012 F1000 Med Rep pmid:22500191
Bataille S et al. Vancomycin-induced Henoch-Schönlein purpura: a case report. 2012 J Med Case Rep pmid:22490390
Buyck JM et al. Increased susceptibility of Pseudomonas aeruginosa to macrolides and ketolides in eukaryotic cell culture media and biological fluids due to decreased expression of oprM and increased outer-membrane permeability. 2012 Clin. Infect. Dis. pmid:22573850
Shimizu T and Shimizu S Azithromycin inhibits mucus hypersecretion from airway epithelial cells. 2012 Mediators Inflamm. pmid:22577246
Chang CS et al. Synthesis and bioevaluation of novel 3,4,5-trimethoxybenzylbenzimidazole derivatives that inhibit Helicobacter pylori-induced pathogenesis in human gastric epithelial cells. 2012 Eur J Med Chem pmid:22217866
Farfan-Portet MI et al. Patient socioeconomic determinants of the choice of generic versus brand name drugs in the context of a reference price system: evidence from Belgian prescription data. 2012 Eur J Health Econ pmid:22427042
Kargar M et al. Real-time PCR for Helicobacter pylori quantification and detection of clarithromycin resistance in gastric tissue from patients with gastrointestinal disorders. 2012 Res. Microbiol. pmid:22177975
Mégraud F The challenge of Helicobacter pylori resistance to antibiotics: the comeback of bismuth-based quadruple therapy. 2012 Therap Adv Gastroenterol pmid:22423259
Srivastav NC et al. Antimycobacterial activities of 5-alkyl (or halo)-3'-substituted pyrimidine nucleoside analogs. 2012 Bioorg. Med. Chem. Lett. pmid:22178557
Scheel AH et al. Talcum induced pneumoconiosis following inhalation of adulterated marijuana, a case report. 2012 Diagn Pathol pmid:22420484
Ishii H et al. Clarithromycin has limited effects in non-elderly, non-severe patients with seasonal influenza virus A infection. 2012 J. Infect. pmid:22178990
Brüning J et al. Erythromycin A dimethyl sulfoxide disolvate 1.43-hydrate. 2012 Acta Crystallogr Sect E Struct Rep Online pmid:22412590
Aoyama N et al. Clarithromycin suppresses the periodontal bacteria-accelerated abdominal aortic aneurysms in mice. 2012 J. Periodont. Res. pmid:22181324
Noguchi S et al. Clarithromycin monohydrate: a synchrotron X-ray powder study. 2012 Acta Crystallogr Sect E Struct Rep Online pmid:22412567
Slany M et al. Mycobacterium marinum infections in humans and tracing of its possible environmental sources. 2012 Can. J. Microbiol. pmid:22182182
Karne SS et al. Mycobacterium avium-intracellulare brain abscess in HIV-positive patient. 2012 Ann Indian Acad Neurol pmid:22412276
Yanai A et al. Non-bismuth quadruple therapy for first-line Helicobacter pylori eradication: A randomized study in Japan. 2012 World J Gastrointest Pharmacol Ther pmid:22408744
McNulty CA et al. Is Helicobacter pylori antibiotic resistance surveillance needed and how can it be delivered? 2012 Aliment. Pharmacol. Ther. pmid:22469191
Polat Z et al. Comparison of levofloxacin-containing sequential and standard triple therapies for the eradication of Helicobacter pylori. 2012 Eur. J. Intern. Med. pmid:22284248
Jakopović IP et al. Novel desosamine-modified 14- and 15-membered macrolides without antibacterial activity. 2012 Bioorg. Med. Chem. Lett. pmid:22503348
Siqueira JF et al. Pyrosequencing as a tool for better understanding of human microbiomes. 2012 J Oral Microbiol pmid:22279602
O'Brien DP et al. Successful outcomes with oral fluoroquinolones combined with rifampicin in the treatment of Mycobacterium ulcerans: an observational cohort study. 2012 PLoS Negl Trop Dis pmid:22272368